BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 32464633)

  • 1. Microfibril-Associated Protein 2 (MFAP2) Potentiates Invasion and Migration of Melanoma by EMT and Wnt/β-Catenin Pathway.
    Chen Z; Lv Y; Cao D; Li X; Li Y
    Med Sci Monit; 2020 May; 26():e923808. PubMed ID: 32464633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of MFAP2 for diagnosis, prognosis and immunotherapy of triple-negative breast cancer.
    Yu J; Wang F; Dong R; Jia W
    Am J Transl Res; 2024; 16(4):1322-1336. PubMed ID: 38715831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MFAP2 Promotes the Proliferation of Cancer Cells and Is Associated With a Poor Prognosis in Hepatocellular Carcinoma.
    Zhu X; Cheng Y; Wu F; Sun H; Zheng W; Jiang W; Shi J; Ma S; Cao H
    Technol Cancer Res Treat; 2020; 19():1533033820977524. PubMed ID: 33280519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA LCPAT1 Upregulation Promotes Breast Cancer Progression via Enhancing MFAP2 Transcription.
    Gong X; Dong T; Niu M; Liang X; Sun S; Zhang Y; Li Y; Li D
    Mol Ther Nucleic Acids; 2020 Sep; 21():804-813. PubMed ID: 32791452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular structure and function of microfibrillar-associated proteins in skeletal and metabolic disorders and cancers.
    Zhu S; Ye L; Bennett S; Xu H; He D; Xu J
    J Cell Physiol; 2021 Jan; 236(1):41-48. PubMed ID: 32572962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MFAP2 is a Potential Diagnostic and Prognostic Biomarker That Correlates with the Progression of Papillary Thyroid Cancer.
    Dong SY; Chen H; Lin LZ; Jin L; Chen DX; Wang OC; Ye ZQ
    Cancer Manag Res; 2020; 12():12557-12567. PubMed ID: 33324100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically predicted circulating protein biomarkers and ovarian cancer risk.
    Considine DPC; Jia G; Shu X; Schildkraut JM; Pharoah PDP; Zheng W; Kar SP;
    Gynecol Oncol; 2021 Feb; 160(2):506-513. PubMed ID: 33246661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MFAP2 aggravates tumor progression through activating FOXM1/β-catenin-mediated glycolysis in ovarian cancer.
    Zhao LQ; Sun W; Zhang P; Gao W; Fang CY; Zheng AW
    Kaohsiung J Med Sci; 2022 Aug; 38(8):772-780. PubMed ID: 35546486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MFAP2, upregulated by m1A methylation, promotes colorectal cancer invasiveness via CLK3.
    Xue M; Mi S; Zhang Z; Wang H; Chen W; Wei W; Lou G
    Cancer Med; 2023 Apr; 12(7):8403-8414. PubMed ID: 36583532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer.
    Shan Z; Wang W; Tong Y; Zhang J
    Med Sci Monit; 2021 Mar; 27():e929558. PubMed ID: 33758160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of microfibrillar-associated protein 2 in cancer.
    Xu W; Wang M; Bai Y; Chen Y; Ma X; Yang Z; Zhao L; Li Y
    Front Oncol; 2022; 12():1002036. PubMed ID: 36530974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Characteristics and Prognostic Role of MFAP2 in Stomach Adenocarcinoma.
    Tang F; Hu C; Long Z; Liu Y; Li G
    J Healthc Eng; 2022; 2022():1417238. PubMed ID: 35356627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA-KCNQ1OT1 mediates miR-423-5p/microfibril-associated protein 2 axis in colon adenocarcinoma.
    Yin X; Jiang A; Ma Z; Lu X; Li D; Chen Y
    Histol Histopathol; 2021 Oct; 36(10):1099-1110. PubMed ID: 34704601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MFAP2 enhances cisplatin resistance in gastric cancer cells by regulating autophagy.
    Li M; Zhang HY; Zhang RG
    PeerJ; 2023; 11():e15441. PubMed ID: 37304872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microfibril-associated protein 2 is activated by POU class 2 homeobox 1 and promotes tumor growth and metastasis in tongue squamous cell carcinoma.
    Yan B; Sun Q; Zhou H; Cao X
    Hum Cell; 2023 Mar; 36(2):822-834. PubMed ID: 36527580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-Cancer Analysis of Microfibrillar-Associated Protein 2 (MFAP2) Based on Bioinformatics and qPCR Verification.
    Qiu Z; Xin M; Wang C; Zhu Y; Kong Q; Liu Z
    J Oncol; 2022; 2022():8423173. PubMed ID: 35211173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global colorectal cancer burden in 2020 and projections to 2040.
    Xi Y; Xu P
    Transl Oncol; 2021 Oct; 14(10):101174. PubMed ID: 34243011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and biological hallmarks of colorectal cancer.
    Li J; Ma X; Chakravarti D; Shalapour S; DePinho RA
    Genes Dev; 2021 Jun; 35(11-12):787-820. PubMed ID: 34074695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil extracellular traps promote metastasis in gastric cancer patients with postoperative abdominal infectious complications.
    Xia X; Zhang Z; Zhu C; Ni B; Wang S; Yang S; Yu F; Zhao E; Li Q; Zhao G
    Nat Commun; 2022 Feb; 13(1):1017. PubMed ID: 35197446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N
    Wang Y; Wang J; Li X; Xiong X; Wang J; Zhou Z; Zhu X; Gu Y; Dominissini D; He L; Tian Y; Yi C; Fan Z
    Nat Commun; 2021 Nov; 12(1):6314. PubMed ID: 34728628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.